You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ORPHENGESIC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Orphengesic, and when can generic versions of Orphengesic launch?

Orphengesic is a drug marketed by Galt Pharms and is included in one NDA.

The generic ingredient in ORPHENGESIC is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.

US Patents and Regulatory Information for ORPHENGESIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galt Pharms ORPHENGESIC aspirin; caffeine; orphenadrine citrate TABLET;ORAL 075141-001 May 29, 1998 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Galt Pharms ORPHENGESIC FORTE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 075141-002 May 29, 1998 RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.